Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Befund ENDO MAG CPGGS Sub MS University Hospital Muenster (UKM) Subform

- 4/3/20 - 1 formulario, 1 itemgroup, 19 items, 1 idioma

Itemgroup: Bile duct stenosis

Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: Befund ENDO MAG CPGGS Sub.

Safety, tolerability and pharmacokinetics of single, ascending and twice-daily repeat doses of intranasal SB-705498 NCT00907933 - Nasal Endoscopy (Period 1 -5; Day 1 - Day 16)

- 6/11/19 - 1 formulario, 3 itemgroups, 45 items, 1 idioma

Itemgroups: Visual Nasal Endoscopy (Period 1 - 5), Nasal Endoscopy (Day 1 - 13), Nasal Endoscopy (Day 14 - 16)

Study ID: 111610 Clinical Study ID: 111610 Study Title: A randomised, double-blind, placebo-controlled study in healthy volunteers to examine the safety, tolerability and pharmacokinetics of a) single, ascending and b) twice-daily repeat doses of intranasal SB-705498. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00907933 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: SB705498, Placebo Study Indication: Rhinitis

Safety, tolerability and pharmacokinetics of single, ascending and twice-daily repeat doses of intranasal SB-705498 NCT00907933 - Logs/ Repeats - 12-Lead ECG; ECG Abnormalities; Repeat- Pharmacokinetics Blood; Repeat Visual Analogue Scale; Repeat Nasal Endoscopy; Repeat Visual Nasal Examination

- 29/10/19 - 1 formulario, 5 itemgroups, 51 items, 1 idioma

Itemgroups: 12-Lead ECG, 12-Lead ECG Abnormalities, Repeat Pharmacokinetics Blood, Repeat Visual Analogue Scale, Repeat Visual Nasal Endoscopy

Study ID: 111610 Clinical Study ID: 111610 Study Title: A randomised, double-blind, placebo-controlled study in healthy volunteers to examine the safety, tolerability and pharmacokinetics of a) single, ascending and b) twice-daily repeat doses of intranasal SB-705498. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00907933 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: SB705498, Placebo Study Indication: Rhinitis

Safety, tolerability and pharmacokinetics of single, ascending and twice-daily repeat doses of intranasal SB-705498 NCT00907933 - Screen - Date of Visit; Demography; Eligibility Question; Subject Identification; Randomisation Number; Nasal Endoscopy

- 26/10/19 - 1 formulario, 17 itemgroups, 33 items, 1 idioma

Itemgroups: Inform Screening, Inform Enrolment, Date of Visit, Demography, Eligibility Question, Subject Identification, Randomisation Number, Nasal Endoscopy - Screening, Nasal Endoscopy - Colour of Mucosa, Nasal Endoscopy - Turbinate Swelling, Nasal Endoscopy - Alignment of the Septum, Nasal Endoscopy - Secretions, Nasal Endoscopy - Infection, Nasal Endoscopy - Post Nasal Drip, Nasal Endoscopy - Crusting, Nasal Endoscopy - Signs of Bleeding, Nasal Endoscopy - Nasal Polyps

Study ID: 111610 Clinical Study ID: 111610 Study Title: A randomised, double-blind, placebo-controlled study in healthy volunteers to examine the safety, tolerability and pharmacokinetics of a) single, ascending and b) twice-daily repeat doses of intranasal SB-705498. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00907933 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: SB705498, Placebo Study Indication: Rhinitis